Skip to content
GLP-1 Desk
Menu
Dispatch #278

NuuVim

NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

Visit NuuVim ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$79/mo (all doses, 3-mo plan, new patients only, compounded)
Tirzepatide
$133/mo (all doses, 3-mo plan, new patients only, compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh NuuVim against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: NuuVim vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency84/100
State access24/100
Molecule range90/100
Onboarding speed60/100
Support responsiveness58/100
Licensing & trust37/100

What the Desk likes

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

Where points come off

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

The Desk's briefing — C

Best for: Readers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.

NuuVim ranks #278 of 498 providers scored — see #1, CoreAge Rx on the board.

Visit NuuVim ↗

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect NuuVim's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on NuuVim's site. Not medical advice; see our disclosure.

← Back to The Desk